{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:28:15Z","timestamp":1786735695898,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jcrt.jcrt_317_17","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T07:20:25Z","timestamp":1540884025000},"page":"170","source":"Crossref","is-referenced-by-count":0,"title":["Human papillomavirus-negative epithelial proliferations resembling condylomata acuminata in a patient receiving vemurafenib for Stage IV melanoma"],"prefix":"10.4103","volume":"16","author":[{"given":"MarnixH","family":"Geukes Foppen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MariekeA","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChristianU","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MarianneB","family":"Crijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.244452-1","first-page":"2507","volume-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1482.244452-2","first-page":"358","volume-title":"Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"key-10.4103\/0973-1482.244452-3","first-page":"1691","volume-title":"Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: A study of 42 patients","author":"Boussemart","year":"2013","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0973-1482.244452-4","first-page":"2238","volume-title":"Vemurafenib cooperates with HPV to promote initiation of cutaneous tumors","author":"Holderfield","year":"2014","journal-title":"Cancer Res"},{"key":"key-10.4103\/0973-1482.244452-5","first-page":"1153","volume-title":"Cutaneous manifestations of dabrafenib (GSK2118436): A selective inhibitor of mutant BRAF in patients with metastatic melanoma","author":"Anforth","year":"2012","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0973-1482.244452-6","first-page":"207","volume-title":"RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors","author":"Su","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1482.244452-7","first-page":"2175","volume-title":"Validation of the SPF10 liPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples","author":"Dal","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0973-1482.244452-8","first-page":"2399","volume-title":"Selective and potent Raf inhibitors paradoxically stimulate normal cell proliferation and tumor growth","author":"Carnahan","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"key-10.4103\/0973-1482.244452-9","first-page":"1180","volume-title":"Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations","author":"Schrama","year":"2014","journal-title":"JAMA Dermatol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:32:37Z","timestamp":1786732357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_317_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["244452"],"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_317_17","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}